Patrick Crowley founded Callum Consultancy after retiring from GlaxoSmithKline as a Vice-President in Pharmaceutical Development. Crowley brings over 40 years of experience in dosage form development in R&D-based organisations. He has helped design and obtain regulatory approval for 15 commercial products including: NCEs, line extensions, semi synthetics, fermentation products and a biopharm product. He holds a Pharmacy Degree from University College Dublin.